BIOMAT Database Logo BIOMAT Database Logo

Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects. 1981

J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
[Hemodynamic and clinical effects of captopril in congestive heart failure].
January 1985, Giornale italiano di cardiologia,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
[Long-term treatment of congestive heart failure with captopril].
April 1990, Zhonghua xin xue guan bing za zhi,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Long-term treatment of congestive heart failure with captopril.
January 1982, British journal of clinical pharmacology,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Long-term captopril therapy in congestive heart failure: serial hemodynamic and echocardiographic changes.
October 1982, American heart journal,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Short-term hemodynamic effects of captopril in infants with congestive heart failure.
January 1988, American journal of diseases of children (1960),
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
August 1985, American heart journal,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
January 1982, British journal of clinical pharmacology,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Hemodynamic and clinical effects of captopril in patients with severe congestive heart failure.
June 1989, Cardiologia (Rome, Italy),
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Long-term control of congestive heart failure with captopril.
April 1982, The American journal of cardiology,
J G Kayanakis, and J M Fauvel, and P Giraud, and J P Bounhoure
Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
April 1982, American heart journal,
Copied contents to your clipboard!